Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Plos One|February 6, 2013
Production of LacZ inducible T cell hybridoma specific for human and mouse gp100₂₅₋₃₃ peptidesGal Cafri, Adi Sharbi-Yunger, Esther Tzehoval, et al.
International Journal of Cancer|August 6, 2019
Optimizing T-cell receptor avidity with somatic hypermutationDavid Bassan, Yosi Meir Gozlan, Adi Sharbi-Yunger, et al.
Oncoimmunology|July 30, 2016
mRNA-based dendritic cell immunization improves survival in ret transgenic mouse melanoma modelAdi Sharbi-Yunger, Mareike Grees, Esther Tzehoval, et al.
International Journal of Cancer|February 18, 2022
On the development of a neoantigen vaccine for the prevention of Lynch SyndromeAdam Solomon, Zoya Alteber, David Bassan, et al.
European Journal of Immunology|April 9, 2021
Avidity optimization of a MAGE-A1-specific TCR with somatic hypermutationDavid Bassan, Yosi Meir Gozlan, Adi Sharbi-Yunger, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 23, 2015
mRNA-transfected Dendritic Cells Expressing Polypeptides That Link MHC-I Presentation to Constitutive TLR4 Activation Confer Tumor ImmunityGal Cafri, Adi Sharbi-Yunger, Esther Tzehoval, et al.
Immunology and Cell Biology|January 23, 2018
The anti-inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiotaZoya Alteber, Adi Sharbi-Yunger, Meirav Pevsner-Fischer, et al.
International Journal of Cancer|August 15, 2018
A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survivalAdi Sharbi-Yunger, Mareike Grees, Gal Cafri, et al.
Oncoimmunology|June 15, 2018
Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma modelsMareike Grees, Adi Sharbi-Yunger, Christos Evangelou, et al.
Journal for Immunotherapy of Cancer|December 14, 2023
HER2 and HLA-A*02 dual CAR-T cells utilize LOH in a NOT logic gate to address on-target off-tumor toxicityDavid Bassan, Leehee Weinberger, Jason Yi, et al.
Pageof 1